Apoptosis is critical for drug response in vivo
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 4 (2) , 132-134
- https://doi.org/10.1054/drup.2001.0188
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Does resistance to apoptosis affect clinical response to antitumor drugs?Drug Resistance Updates, 2001
- Genetic analysis of chemoresistance in primary murine lymphomasNature Medicine, 2000
- In vivo veritas: Bcl-2 and Bcl-XLmediate tumor cell resistance to chemotherapyDrug Resistance Updates, 2000
- Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse ModelPublished by Elsevier ,1999
- INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53Genes & Development, 1999
- Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas.Endocrine-Related Cancer, 1999
- Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell deathInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Apoptosis and therapyThe Journal of Pathology, 1999
- P53 Gene Mutations in Lymphoid Diseases and Their Possible Relevance to Drug ResistanceLeukemia & Lymphoma, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994